205 related articles for article (PubMed ID: 24988892)
1. Interleukin 6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation.
Yan HQ; Huang XB; Ke SZ; Jiang YN; Zhang YH; Wang YN; Li J; Gao FG
Cancer Sci; 2014 Sep; 105(9):1220-7. PubMed ID: 24988892
[TBL] [Abstract][Full Text] [Related]
2. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells.
Ke SZ; Ni XY; Zhang YH; Wang YN; Wu B; Gao FG
Int J Oncol; 2013 Apr; 42(4):1289-96. PubMed ID: 23381786
[TBL] [Abstract][Full Text] [Related]
3. Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxia‑telangiectasia mutated and nuclear factor‑κB pathways in gastric cancer cells.
Zhuang X; Li X; Zhang J; Hu Y; Hu B; Shi Y; Sun Y; Hong G
Oncol Rep; 2018 Oct; 40(4):2334-2342. PubMed ID: 30106453
[TBL] [Abstract][Full Text] [Related]
4. Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance.
van Oosterwijk JG; Herpers B; Meijer D; Briaire-de Bruijn IH; Cleton-Jansen AM; Gelderblom H; van de Water B; Bovée JV
Ann Oncol; 2012 Jun; 23(6):1617-26. PubMed ID: 22112972
[TBL] [Abstract][Full Text] [Related]
5. An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.
Wu G; Song L; Zhu J; Hu Y; Cao L; Tan Z; Zhang S; Li Z; Li J
Cancer Res; 2018 Nov; 78(22):6399-6412. PubMed ID: 30254148
[TBL] [Abstract][Full Text] [Related]
6. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
[TBL] [Abstract][Full Text] [Related]
7. Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cells.
Yan HQ; Zhang D; Shi YY; You X; Shi L; Li Q; Gao FG
Oncotarget; 2016 Sep; 7(38):62070-62083. PubMed ID: 27556690
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced interleukin-6 expression through MAPK/p38/NF-kappaB signaling pathway and the resultant antiapoptotic effect on endothelial cells through Mcl-1 expression with sIL6-Ralpha.
Chou CH; Chen SU; Cheng JC
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1553-61. PubMed ID: 19931737
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin.
Momeny M; Zakidizaji M; Ghasemi R; Dehpour AR; Rahimi-Balaei M; Abdolazimi Y; Ghavamzadeh A; Alimoghaddam K; Ghaffari SH
Med Oncol; 2010 Sep; 27(3):833-42. PubMed ID: 19763917
[TBL] [Abstract][Full Text] [Related]
10. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
11. MAPKs and NF-κB-mediated acrylamide-induced neuropathy in rat striatum and human neuroblastoma cells SY5Y.
Yan D; Pan X; Yao J; Wang D; Wu X; Chen X; Shi N; Yan H
J Cell Biochem; 2019 Mar; 120(3):3898-3910. PubMed ID: 30368882
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6-triggered ataxia-telangiectasia mutated kinase activation facilitates epithelial-to-mesenchymal transition in lung cancer by upregulating vimentin expression.
Jiang YN; Ni XY; Yan HQ; Shi L; Lu NN; Wang YN; Li Q; Gao FG
Exp Cell Res; 2019 Aug; 381(2):165-171. PubMed ID: 31100307
[TBL] [Abstract][Full Text] [Related]
13. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.
Sims JT; Ganguly SS; Bennett H; Friend JW; Tepe J; Plattner R
PLoS One; 2013; 8(1):e55509. PubMed ID: 23383209
[TBL] [Abstract][Full Text] [Related]
14. MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway.
Chen PM; Cheng YW; Wu TC; Chen CY; Lee H
Free Radic Biol Med; 2015 Feb; 79():127-37. PubMed ID: 25499851
[TBL] [Abstract][Full Text] [Related]
15. NF-κB activation fails to protect cells to TNFα-induced apoptosis in the absence of Bcl-xL, but not Mcl-1, Bcl-2 or Bcl-w.
Casanelles E; Gozzelino R; Marqués-Fernández F; Iglesias-Guimarais V; Garcia-Belinchón M; Sánchez-Osuna M; Solé C; Moubarak RS; Comella JX; Yuste VJ
Biochim Biophys Acta; 2013 May; 1833(5):1085-95. PubMed ID: 23369735
[TBL] [Abstract][Full Text] [Related]
16. [Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway].
Zhu Y; Shi YJ; Zhao YL; Zhu P
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):318-325. PubMed ID: 29643533
[TBL] [Abstract][Full Text] [Related]
17. PACS-2 mediates the ATM and NF-κB-dependent induction of anti-apoptotic Bcl-xL in response to DNA damage.
Barroso-González J; Auclair S; Luan S; Thomas L; Atkins KM; Aslan JE; Thomas LL; Zhao J; Zhao Y; Thomas G
Cell Death Differ; 2016 Sep; 23(9):1448-57. PubMed ID: 26943323
[TBL] [Abstract][Full Text] [Related]
18. Gentiopicrin exerts anti-rheumatic effect in human fibroblast-like synoviocytes via inhibition of p38MAPK/NF-κB pathway.
Zhang N; Jiang Y; Mu F; Wu H; You Q
Cell Mol Biol (Noisy-le-grand); 2019 Aug; 65(6):85-90. PubMed ID: 31472052
[TBL] [Abstract][Full Text] [Related]
19. p38 mitogen-activated protein kinase-induced nuclear factor kappa-light-chain-enhancer of activated B cell activity is required for neuroprotection in retinal ischemia/reperfusion injury.
Jiang SY; Zou YY; Wang JT
Mol Vis; 2012; 18():2096-106. PubMed ID: 22876136
[TBL] [Abstract][Full Text] [Related]
20. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
